News

Technology News

Invatec Gets CE Mark For Drug Eluting Balloon

Tuesday, March 17, 2009 5:17:00 AM PDT | VentureDeal Staff
Bethlehem, Pennsylvania  --  Medical device company Invatec announced that it has received the CE Mark for a second drug eluting balloon platform.

The system, called IN.PACT, is a coronary balloon that features a proprietary coating that frees and separates paclitaxel molecules and helps them absorb into the wall of the artery.

“We are extremely excited to commercialize a much-needed product that combines our FreePac coating technology with the performance-leading characteristics of our Falcon PTCA balloon platform, thereby creating a world class drug eluting balloon,” commented Andrea Venturelli and Stefan Widensohler, co-founders of Invatec. “The European availability of IN.PACT Falcon underscores our mission to provide physicians with the option of using drug eluting balloons for specific clinical indications throughout the coronary and peripheral anatomy. The launch of IN.PACT Falcon, our second drug eluting balloon platform, aligns with our strategy to leverage FreePac on all of our major balloon platforms.”

Email Page  Email Page | Print Page Print Page

Free Trial

Want unlimited access to the complete database with thousands of technology companies, VCs and transactions for only $25 per month?

Start your Free 14 Day Trial now – no obligation or credit card required.

Free 14 day trial. No Obligation. Click to Register.
Venturedeal Twitter Venturedeal Facebook Venturedeal Linkedin


PCI - Level1